Lv7
4950 积分 2022-08-18 加入
Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth
1个月前
已完结
DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer
1个月前
已完结
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance
1个月前
已完结
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance
1个月前
已完结
RNF138 promotes cisplatin resistance and PD-L1-mediated immune evasion via JAK2/STAT3 activation in nasopharyngeal carcinoma
2个月前
已完结
CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
2个月前
已完结
N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation
2个月前
已完结
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study
4个月前
已完结
Integrative Multiomics Analyses Identify Molecular Subtypes of Head and Neck Squamous Cell Carcinoma with Distinct Therapeutic Vulnerabilities
5个月前
已完结
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
5个月前
已完结
皖公网安备34019202002308
